Barriers and enablers to the implementation of Safewards and the alignment to the i-PARIHS framework - a qualitative systematic review - Bj örkdahl A, Johansson U, Kjellin L, Pelto-Piri V.
Inpatient mental healthcare settings should offer safe environments for patients to heal and recover and for staff to provide high-quality treatment and care. However, aggressive patient behaviour, unengaged staff approaches, and the use of restrictive pra...
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news

PROTOCOL: Treatment for depressive disorder among adults: an evidence and gap map of systematic reviews - Guo L, Li J, White H, Xu Z, Ren J, Huang X, Chen Y, Yang K.
The objective of the map is to map available systematic reviews on the effectiveness of treatments for depressive disorders among adults. Specifically, this EGM includes studies on the effectiveness...
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news

Dentistry one participates in 2023 national association of dental plans (nadp) “converge” conference
Discussion, “Creative Strategies to Engage with High-Risk Members through Teledentistry” September 20, 10 a.m. – 11 a.m. PT, Room Cobalt 500 Metuchen, N.J. – September 18, 2023 – Dentistry.One, a virtual-first dental care solution introduced by MouthWatch, LLC, is the highlight at Booth #501 during this week’s National Association of Dental Plans “CONVERGE” Conference at the Hilton San Diego Bayfront in California. “A growing number of today’s consumers expect a telehealth option to help manage their healthcare, including their oral health,” said Brant Herman, Founder and Chief Executive Officer ...
Source: Dental Technology Blog - September 19, 2023 Category: Dentistry Source Type: news

Stewart Cameron obituary
Leading British nephrologist who founded an internationally renowned kidney unit at Guy ’s hospital in LondonAs a bright young doctor at Guy ’s hospital in London in the 1960s, Stewart Cameron, who has died aged 89, was determined to be both clinician and researcher, but where should he focus his talents? Irreversible kidney failure – uniformly fatal until then – was just becoming treatable through dialysis or kidney transplantatio n; both were complex, demanding and dangerous, for patients and doctors alike.Stewart had found his metier and decided to make renal medicine his life ’s work. The first professor of r...
Source: Guardian Unlimited Science - September 19, 2023 Category: Science Authors: John Feehally Tags: Medical research Science Doctors Health Aberdeen Hospitals Source Type: news

Extended-Release Buprenorphine Not Necessarily Cost-Effective
TUESDAY, Sept. 19, 2023 -- For patients with opioid use disorder (OUD), treatment with extended-release buprenorphine is not cost-effective when transmucosal buprenorphine is available, according to a study published online Sept. 13 in JAMA Network...
Source: Drugs.com - Pharma News - September 19, 2023 Category: Pharmaceuticals Source Type: news

How To Avoid China ’ s Medicine Monopoly
I want to share a shocking statistic with you… Around 80% of all the pharmaceuticals sold in America — both prescription and over-the-counter — are manufactured in China. I’m talking about drugs for Parkinson’s and Alzheimer’s, blood pressure and blood thinners, diuretics, aspirin, antibiotics, and a big chunk of the world’s insulin and diabetes drugs — just to name a few.1 We don’t even make penicillin anymore. The last penicillin plant in the U.S. closed its doors in 2004. Americans who rely on medicine are now almost entirely at the mercy of a country whose relations with the U.S. have become more ...
Source: Al Sears, MD Natural Remedies - September 19, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Source Type: news

Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era
The American College of Physicians has issued an updated version of its living, rapid practice point guideline on the best treatment options for outpatients with confirmed COVID-19.MDedge News
Source: Medscape Pharmacist Headlines - September 19, 2023 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Antibiotics Destroy Memories?
Even in my earliest days of practicing medicine, I was never a big fan of prescribing antibiotics – except, of course, in cases of extreme or life-threatening infections. Because even back then, I was concerned about the damage these drugs could cause to your gut. That’s because trillions of microscopic bacteria – some that protect against certain diseases and some that can cause disease – live in your microbiome and exist in a delicate balance with each other. The problem is that antibiotics can’t distinguish between so-called “good” bacteria and the “bad” ones causing the infection. These drugs kill eve...
Source: Al Sears, MD Natural Remedies - September 19, 2023 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Source Type: news

Unlicensed New York City acupuncturist charged after patient's lungs collapsed, prosecutors say
Prosecutors have charged a New York City man with performing acupuncture without a license after they say he punctured a woman’s lungs during treatment, sending her to a hospital for emergency surgery
Source: ABC News: Health - September 19, 2023 Category: Consumer Health News Tags: Health Source Type: news

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE:... Devices, Mergers & Acquisitions Boston Scientific, Relievant Medsystems, Intracept System, vertebrogenic pain
Source: HSMN NewsFeed - September 19, 2023 Category: Pharmaceuticals Source Type: news

Apremilast for the Treatment of Palmoplantar Pustulosis Apremilast for the Treatment of Palmoplantar Pustulosis
This study assessed the efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, for the treatment of Japanese patients with palmoplantar pustulosis refractory to topical therapy.American Journal of Clinical Dermatology
Source: Medscape Today Headlines - September 19, 2023 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Lifetime suicidal-related behaviour among patients in treatment for substance use disorder: a cross-sectional study - Siria S, Leza L, L ópez-Goñi JJ, Fernandez-Montalvo J.
We describe and c...
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Methods of treatment for violent adolescents - Schmeck K.
There have been numerous attempts to treat and rehabilitate juvenile offenders throughout the contemporary history of juvenile justice. By the 1980s, therapeutic nihilism had set in due to the significant failure of the majority of these endeavours [1]. Ho...
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

A 10-year single-burn center review of free tissue transfer for burn-related injuries - Alessandri Bonetti M, Jeong T, Stofman GM, Egro FM.
Skin grafting is the mainstay treatment in burn patients. However, in the scenario of soft tissue deficit along with exposure of critical structures, free flap is the only reconstructive option to provide adequate coverage. The aim of the study is to revie...
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Sleep disorders symptoms in children, adolescents, and emerging adults: reducing mortality and population health burden through improved identification, referral, and treatment - Gorovoy SB, Tubbs AS, Grandner MA.
Suicide is the second-leading cause of death in all age groups from ages 10-34. Identifying risk factors for suicide in these age groups--especially those that may be amenable to intervention--may represent an opportunity to reduce the societal impact of s...
Source: SafetyLit - September 19, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20